UK MHRA consults on vigilance reporting of joint replacement implants
This article was originally published in RAJ Devices
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency has issued revised draft guidance advising manufacturers of CE-marked joint replacement implants on how to report adverse events involving their products under the Medical Devices Vigilance System1.